BRIEF-EMA Recommends Conditional Marketing Authorisation For Tecvayli For Multiple Myeloma Patients


Reuters | Updated: 22-07-2022 16:50 IST | Created: 22-07-2022 16:34 IST
BRIEF-EMA Recommends Conditional Marketing Authorisation For Tecvayli For Multiple Myeloma Patients
European Medicines Agency Image Credit: Twitter(@EMA_News)

European Medicines Agency:

* EMA: NEW MEDICINE FOR MULTIPLE MYELOMA PATIENTS WITH LIMITED TREATMENT OPTIONS: 22/07/2022

* EMA: RECOMMENDED CONDITIONAL MARKETING AUTHORISATION IN EU FOR TECVAYLI FOR TREATMENT OF ADULT PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback